Structure−Activity Relationships for the Binding of Arylpiperazines and Arylbiguanides at 5-HT3 Serotonin Receptors-Reference-Cited by-同舟云学术

Structure−Activity Relationships for the Binding of Arylpiperazines and Arylbiguanides at 5-HT3 Serotonin Receptors

Published:1996-01-01 Issue:20 Volume:39 Page:4017-4026
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Dukat Małgorzata¹,Abdel-Rahman Ashraf A.¹,Ismaiel Abd M.¹,Ingher Stacy¹,Teitler Milt¹,Gyermek Laszlo¹,Glennon Richard A.¹

Affiliation:

1. Department of Medicinal Chemistry, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0540, Department of Pharmacology, Albany Medical College, Albany, New York 12208, and Department of Anesthesiology, UCLA School of Medicine/Harbor UCLA Medical Center, Torrance, California 90509-2910

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm9603936

Reference64 articles.

1. 5-HT3 receptors

2. The psychopharmacology of 5-HT3 receptors

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quipazine: Classical hallucinogen? Novel psychedelic?;Australian Journal of Chemistry;2023-05-02

2. Computational analysis of non-competitive antagonist arylguanidine-α7 nAChR complexes;Journal of Molecular Graphics and Modelling;2021-09

3. N1H- and N1-Substituted Phenylguanidines as α7 Nicotinic Acetylcholine (nACh) Receptor Antagonists: Structure–Activity Relationship Studies;ACS Chemical Neuroscience;2021-05-27

4. Recent advances with 5‐HT3modulators for neuropsychiatric and gastrointestinal disorders;Medicinal Research Reviews;2020-03

5. 5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface;Pharmacological Reviews;2019-06-26